Delisting riskPopularity #4,736
Change Agents (CHGA)
Agentic video and AI-search tools alongside KetoAir breathalyzer distribution.
$2.14
After-hours close+0.09 (+4.39%)
At close$2.05(−0.49%)
In millions of USD, except per-share figures
| In millions | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | −9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Gross profit | −9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 |
| 1 | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 1 | 3 | 1 | |
| Research & development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 1 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Operating income | −10 | −1 | −2 | −1 | −1 | −2 | −2 | −2 | −2 | −3 | −2 |
| 0 | −1 | −1 | 0 | −2 | 0 | −11 | 1 | 0 | −2 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Other non-operating income | −10 | −1 | −2 | −1 | 0 | 0 | 10 | −2 | 0 | 1 | −2 |
| Income before tax | −10 | −1 | −2 | −2 | −3 | −2 | −13 | 0 | −1 | −4 | −2 |
| Net income from continuing operations | −10 | −1 | −2 | −2 | −3 | −2 | −13 | 0 | −1 | −4 | −2 |
| Discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | −10 | −1 | −2 | −2 | −3 | −2 | −13 | 0 | −2 | −4 | −2 |
| EPS, basic | −$260.60 | −$37.20 | −$57.00 | −$36.40 | −$21.40 | −$28.60 | −$124.40 | −$1.20 | $0.00 | −$10.00 | −$2.80 |
| EPS, diluted | −$260.60 | −$37.20 | −$57.00 | −$36.40 | −$21.40 | −$28.60 | −$124.40 | −$1.20 | $0.00 | −$10.00 | −$2.80 |
| Weighted average shares, basic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Weighted average shares, diluted | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| EBITDA | 0 | 0 | 0 | 0 | −1 | −2 | −12 | 0 | −2 | −4 | −1 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| EBIT | 0 | 0 | 0 | 0 | −1 | −2 | −12 | 0 | −2 | −4 | −2 |
